- Home
- WULF vs KYMR Comparison
WULF vs KYMR Comparison
Compare WULF & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WULF | KYMR |
|---|---|---|
| Founded | 1952 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 6.8B |
| IPO Year | 1999 | 2020 |
Fundamental Metrics
Financial Performance| Metric | WULF | KYMR |
|---|---|---|
| Price | $14.91 | $85.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 26 |
| Target Price | $18.54 | ★ $107.72 |
| AVG Volume (30 Days) | ★ 25.5M | 588.0K |
| Earning Date | 05-08-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $168,455,000.00 | $39,211,000.00 |
| Revenue This Year | $123.91 | $11.85 |
| Revenue Next Year | $188.18 | $7.79 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 20.28 | N/A |
| 52 Week Low | $2.06 | $19.45 |
| 52 Week High | $18.51 | $103.00 |
Technical Indicators
Market Signals| Indicator | WULF | KYMR |
|---|---|---|
| Relative Strength Index (RSI) | 48.78 | 56.79 |
| Support Level | $13.98 | $66.33 |
| Resistance Level | $16.93 | $95.90 |
| Average True Range (ATR) | 1.25 | 3.85 |
| MACD | -0.14 | 0.62 |
| Stochastic Oscillator | 38.86 | 83.52 |
Price Performance
Historical ComparisonAbout WULF TeraWulf Inc.
TeraWulf Inc is a digital asset technology company that is engaged in digital infrastructure and sustainable energy development. It is involved in supporting environmentally conscious bitcoin mining operations by developing and operating facilities within the United States. The company's bitcoin mining facilities are powered by clean, affordable, and reliable energy sources. Its primary source of revenue stems from the mining of bitcoin conducted at the company's mining facility sites. Additionally, the company occasionally generates revenue through the provision of miner hosting services to third-party entities.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.